Effect of ramosetron on QTc interval: a randomised controlled trial in patients undergoing off-pump coronary artery bypass surgery

BACKGROUND: Ramosetron is a relatively new 5-hydroxytryptamine three receptor antagonist with higher binding affinity and more prolonged duration of action compared to ondansetron. The present study was performed to evaluate the effects of ramosetron on QTc interval and possible cardiovascular adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae Kyong, Cho, Youn Joung, Lim, Chae-won, Min, Jeong Jin, Choi, Eue-Keun, Hong, Deok Man, Jeon, Yunseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972982/
https://www.ncbi.nlm.nih.gov/pubmed/27488394
http://dx.doi.org/10.1186/s12871-016-0222-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972982/
https://www.ncbi.nlm.nih.gov/pubmed/27488394
http://dx.doi.org/10.1186/s12871-016-0222-1

Ejemplares similares